VIKING GLOBAL INVESTORS LP - Q2 2022 holdings

$21.9 Billion is the total value of VIKING GLOBAL INVESTORS LP's 82 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 44.1% .

 Value Shares↓ Weighting
AMZN BuyAMAZON COM INC$860,822,000
-37.6%
8,104,902
+1816.7%
3.94%
-29.4%
CB BuyCHUBB LIMITED$741,937,000
+8.4%
3,774,226
+17.9%
3.39%
+22.6%
MA BuyMASTERCARD INCORPORATEDcl a$726,331,000
+13.3%
2,302,305
+28.4%
3.32%
+28.2%
ANTM BuyELEVANCE HEALTH INC$706,731,000
+921.1%
1,464,485
+939.4%
3.23%
+1054.6%
CNC BuyCENTENE CORP DEL$701,744,000
+6.8%
8,293,867
+6.2%
3.21%
+20.8%
IFF BuyINTERNATIONAL FLAVORS&FRAGRA$610,085,000
+22.3%
5,121,603
+34.9%
2.79%
+38.4%
BSX BuyBOSTON SCIENTIFIC CORP$546,153,000
-4.0%
14,653,954
+14.1%
2.50%
+8.7%
MCK NewMCKESSON CORP$530,259,0001,625,515
+100.0%
2.42%
RPRX BuyROYALTY PHARMA PLC$520,064,000
+24.0%
12,370,694
+14.9%
2.38%
+40.3%
AIG NewAMERICAN INTL GROUP INC$516,859,00010,108,715
+100.0%
2.36%
HDB BuyHDFC BANK LTDsponsored ads$504,658,000
+16.3%
9,182,277
+29.8%
2.31%
+31.6%
APG BuyAPI GROUP CORP$503,513,000
-28.5%
33,634,813
+0.5%
2.30%
-19.1%
TMO BuyTHERMO FISHER SCIENTIFIC INC$468,626,000
+63.7%
862,587
+78.0%
2.14%
+85.2%
FB BuyMETA PLATFORMS INCcl a$462,121,000
+71.8%
2,865,864
+136.9%
2.11%
+94.5%
MMC BuyMARSH & MCLENNAN COS INC$439,141,000
+14.5%
2,828,603
+25.7%
2.01%
+29.5%
INTU NewINTUIT$429,953,0001,115,487
+100.0%
1.97%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$418,708,000
+44.7%
5,052,593
+34.6%
1.92%
+63.7%
SQ BuyBLOCK INCcl a$344,373,000
+462.4%
5,603,207
+1140.9%
1.58%
+535.1%
UBER BuyUBER TECHNOLOGIES INC$339,301,000
-8.9%
16,583,623
+58.9%
1.55%
+3.1%
LRCX NewLAM RESEARCH CORP$295,759,000694,026
+100.0%
1.35%
AMP BuyAMERIPRISE FINL INC$281,388,000
+1.5%
1,183,896
+28.2%
1.29%
+14.8%
DG BuyDOLLAR GEN CORP NEW$272,481,000
+215.2%
1,110,174
+185.9%
1.25%
+256.0%
TTWO BuyTAKE-TWO INTERACTIVE SOFTWAR$245,019,000
+170.8%
1,999,669
+239.8%
1.12%
+206.3%
ACHC BuyACADIA HEALTHCARE COMPANY IN$235,249,000
+68.5%
3,478,476
+63.3%
1.08%
+90.8%
CTLT BuyCATALENT INC$210,422,000
+0.2%
1,961,249
+3.6%
0.96%
+13.3%
AVTR BuyAVANTOR INC$191,846,000
+63.9%
6,168,685
+78.3%
0.88%
+85.6%
BA BuyBOEING CO$190,210,000
+225.3%
1,391,238
+355.6%
0.87%
+268.6%
DIS NewDISNEY WALT CO$164,398,0001,741,500
+100.0%
0.75%
BKNG BuyBOOKING HOLDINGS INC$156,099,000
+22.6%
89,251
+64.6%
0.71%
+38.6%
UNM BuyUNUM GROUP$146,645,000
+309.1%
4,310,548
+278.9%
0.67%
+362.8%
KRTX BuyKARUNA THERAPEUTICS INC$141,610,000
+14.6%
1,119,360
+14.9%
0.65%
+29.9%
MOH BuyMOLINA HEALTHCARE INC$132,859,000
-4.5%
475,158
+14.0%
0.61%
+8.2%
CRL BuyCHARLES RIV LABS INTL INC$118,413,000
-20.1%
553,409
+6.1%
0.54%
-9.5%
ZLAB BuyZAI LAB LTDadr$114,430,000
-17.0%
3,299,598
+5.3%
0.52%
-6.1%
INSP BuyINSPIRE MED SYS INC$108,724,000
+36.2%
595,193
+91.5%
0.50%
+53.9%
CME NewCME GROUP INC$104,118,000508,639
+100.0%
0.48%
WDC NewWESTERN DIGITAL CORP.$88,153,0001,966,376
+100.0%
0.40%
RH NewRH$85,165,000401,230
+100.0%
0.39%
MU NewMICRON TECHNOLOGY INC$81,295,0001,470,600
+100.0%
0.37%
COUP NewCOUPA SOFTWARE INC$80,787,0001,414,833
+100.0%
0.37%
CLDX BuyCELLDEX THERAPEUTICS INC NEW$63,029,000
+0.2%
2,337,854
+26.6%
0.29%
+13.4%
PHVS BuyPHARVARIS N V$55,071,000
+18.7%
2,491,923
+0.5%
0.25%
+34.0%
SWAV NewSHOCKWAVE MED INC$54,292,000284,000
+100.0%
0.25%
CAR NewAVIS BUDGET GROUP$40,987,000278,673
+100.0%
0.19%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$33,248,000
+189.6%
1,857,424
+60.5%
0.15%
+230.4%
LVS NewLAS VEGAS SANDS CORP$32,411,000964,915
+100.0%
0.15%
NewPEPGEN INC$17,814,0001,793,923
+100.0%
0.08%
VSTM NewVERASTEM INC$10,700,0009,224,000
+100.0%
0.05%
BuyLIANBIOsponsored ads$7,699,000
+38.3%
3,564,173
+137.6%
0.04%
+59.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC36Q3 20237.0%
AMAZON COM INC34Q3 202310.6%
META PLATFORMS INC34Q3 202310.4%
MICROSOFT CORP30Q3 20239.1%
THERMO FISHER SCIENTIFIC INC29Q3 20235.4%
NETFLIX INC26Q2 20236.0%
MASTERCARD INCORPORATED25Q3 20233.9%
ELEVANCE HEALTH INC24Q2 202310.2%
ALPHABET INC22Q2 20219.3%
UNITEDHEALTH GROUP INC22Q3 20235.3%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Celldex Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Coupa Software IncSold outFebruary 14, 202300.0%
FIGS, Inc.Sold outFebruary 14, 202300.0%
Guardant Health, Inc.February 14, 20234,107,6444.0%
Orion Acquisition Corp.Sold outFebruary 14, 202300.0%
PROCEPT BioRobotics CorpSold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outNovember 25, 202200.0%
Cazoo Group LtdNovember 10, 202260,000,0007.3%
AbCellera Biologics Inc.Sold outFebruary 14, 202200.0%
Athira Pharma, Inc.Sold outFebruary 14, 202200.0%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
32024-03-20
SC 13G/A2024-03-20
42024-03-07
42024-03-07
42024-03-01
42024-03-01
SC 13G/A2024-03-01
42024-02-28
42024-02-28
SC 13G/A2024-02-28

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings